Optic Nerve Disorders Development Market: Analyze the Companies, Institutions and Universities Currently Operating in the Pipeline with the Latest Research

This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information from the eye to the brain.

Pune, India – November 6, 2018 /MarketersMedia/ —

Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. Signs and symptoms include eye pain, nausea and vomiting (accompanying the severe eye pain), sudden onset of visual disturbance, often in low light, blurred vision and reddening of the eye. There are 13 products in development for this indication.

Access Report Details at: https://www.themarketreports.com/report/optic-nerve-disorders-drug-development-pipeline-review-2018

Scope
• Which companies are the most active within each pipeline?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&D milestones and data publications to have happened in this disease area?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/1319468

Reasons To Buy
• Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
• Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
• Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
• Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Get this report at: https://www.themarketreports.com/report/buy-now/1319468

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/optic-nerve-disorders-development-market-analyze-the-companies-institutions-and-universities-currently-operating-in-the-pipeline-with-the-latest-research/439660

For more information, please visit https://www.themarketreports.com/report/optic-nerve-disorders-drug-development-pipeline-review-2018

Source: MarketersMedia

Release ID: 439660